CenExel Clinical Research (PRIVATE.CENEXELCLIN)

Overall impact
C (50)

Commentary

CenExel Clinical Research is an average overall performer. With a 'C' rating of 49.7 for overall impact (42nd percentile compared to all companies), CenExel Clinical Research ranks 204th out of 275 industry peers, behind Cerba Healthcare, Allied Physicians Group, Cano Health and 200 others, and ahead of GenesisCare, Southern Veterinary Partners, Eyesouth Partners and 68 others. On top material causes for CenExel Clinical Research's industry (Health Care Providers & Services), CenExel Clinical Research performs well in Child and Maternal Health (95.3 score), Child and Maternal Health (95.3), Child and Maternal Health (95.3) and 12 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (13.7 score), Reduced Use of tobacco (8.1), Humane Treatment of Animals (13.7) and 29 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.CENEXELCLIN
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
1,200
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
#<Country/State:0x00007f903eb47820>, United States
Share classes
PRIVATE.CENEXELCLIN
Description
CenExel is a nationwide clinical research site and patient network serving life sciences companies and helping get therapies to patients faster. It provides medical and scientific support in the design and execution of clinical trials through an integrated network of Centers of Excellence. The company works with pharma, biotech, sponsors, and CROs, combining site services with centralized SOPs, budgeting, contracting, data oversight, and patient recruitment. CenExel emphasizes therapeutic expertise in areas such as psychiatry, vaccines, neurology, analgesia, ethnic bridging, sleep, dermatology, and early phase/translational medicine. Its network includes 18 Centers of Excellence in diverse U.S. metropolitan areas. The company also highlights its state-of-the-art facilities and broad experience across Phase I–IV studies.
Material causes
Ethos considers the following causes material for CenExel Clinical Research, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.